Bicocca Open Archive

Logo unimib boa
SERAVALLE, GINO LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.344
AS - Asia 4.192
EU - Europa 3.294
SA - Sud America 703
Continente sconosciuto - Info sul continente non disponibili 382
AF - Africa 121
OC - Oceania 13
Totale 18.049
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.726
SG - Singapore 1.557
CN - Cina 814
IT - Italia 799
HK - Hong Kong 600
RU - Federazione Russa 569
DE - Germania 561
VN - Vietnam 557
CA - Canada 499
BR - Brasile 497
IE - Irlanda 325
SE - Svezia 300
GB - Regno Unito 166
FR - Francia 159
IN - India 129
AT - Austria 105
BD - Bangladesh 105
UA - Ucraina 87
AR - Argentina 78
ID - Indonesia 70
KR - Corea 64
FI - Finlandia 49
IQ - Iraq 43
TR - Turchia 41
ZA - Sudafrica 41
PK - Pakistan 40
MX - Messico 38
EC - Ecuador 37
JP - Giappone 35
DK - Danimarca 31
CO - Colombia 29
PL - Polonia 26
SA - Arabia Saudita 24
ES - Italia 21
NL - Olanda 20
UZ - Uzbekistan 20
PH - Filippine 17
VE - Venezuela 16
BE - Belgio 14
CR - Costa Rica 13
EG - Egitto 13
MY - Malesia 13
CL - Cile 12
HN - Honduras 12
PY - Paraguay 12
TN - Tunisia 12
JM - Giamaica 11
TT - Trinidad e Tobago 11
PE - Perù 10
AU - Australia 9
ET - Etiopia 8
KE - Kenya 8
TH - Thailandia 8
BG - Bulgaria 7
JO - Giordania 7
MA - Marocco 7
NI - Nicaragua 7
PR - Porto Rico 7
AE - Emirati Arabi Uniti 6
CW - ???statistics.table.value.countryCode.CW??? 6
KG - Kirghizistan 6
LT - Lituania 6
SN - Senegal 6
AL - Albania 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
HU - Ungheria 5
MK - Macedonia 5
NG - Nigeria 5
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
EU - Europa 4
GT - Guatemala 4
IR - Iran 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
RS - Serbia 4
UY - Uruguay 4
EE - Estonia 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
SR - Suriname 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
BJ - Benin 2
CI - Costa d'Avorio 2
GE - Georgia 2
HR - Croazia 2
MU - Mauritius 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
Totale 17.650
Salva come PNG Salva come JPEG
Città #
Ann Arbor 877
Singapore 859
Ashburn 838
Hong Kong 585
San Jose 565
Fairfield 495
Frankfurt am Main 414
Toronto 395
Chandler 317
Dublin 313
Council Bluffs 284
Milan 277
Wilmington 259
New York 246
Houston 222
Woodbridge 221
Seattle 220
Dallas 210
Ho Chi Minh City 165
Santa Clara 142
Dearborn 139
Beijing 137
Chicago 133
Princeton 132
Los Angeles 131
Cambridge 124
Hanoi 124
The Dalles 108
Vienna 96
Hefei 81
Moscow 76
Jacksonville 75
Lauterbourg 69
Rome 67
Altamura 58
Lawrence 56
Seoul 56
Atlanta 55
Buffalo 50
Nanjing 50
Boardman 47
Shanghai 46
São Paulo 44
Jakarta 42
San Diego 36
Dong Ket 33
Montreal 30
Munich 30
Haiphong 28
Orem 28
London 27
North Bergen 26
Brooklyn 25
Helsinki 25
Phoenix 25
Columbus 24
Da Nang 24
Lissone 24
San Francisco 24
Tokyo 24
Denver 23
Guangzhou 23
Baghdad 22
Turin 21
Salt Lake City 20
Andover 19
Warsaw 18
Figino 17
Nanchang 17
Tashkent 17
Kunming 15
Memphis 15
Jiaxing 14
Mumbai 14
Rio de Janeiro 14
Shenyang 14
Belo Horizonte 13
Tianjin 13
Bologna 12
Brussels 12
Changsha 12
Chennai 12
Nuremberg 12
Poplar 12
Quito 12
Boston 11
Charlotte 11
Johannesburg 11
Lahore 11
Miami 11
Jeddah 10
Jinan 10
Manchester 10
Brasília 9
Cairo 9
Hebei 9
Mexico City 9
Philadelphia 9
Pune 9
San José 9
Totale 10.874
Salva come PNG Salva come JPEG
Nome #
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 631
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 376
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 367
Heart rate as cardiovascular risk factor 351
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 348
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 317
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 314
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 303
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 299
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 298
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 295
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 294
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 294
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 293
Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights 287
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 279
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 276
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 271
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 266
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 266
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 252
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 251
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 250
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 243
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 232
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis 231
Sympathetic Nervous System, Sleep, and Hypertension 230
Baroreflex activation therapy systems: current status and future prospects 224
Obesity and Hypertension 223
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome 222
The role of carotid baroreceptor stimulation 222
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 221
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 220
Effects of Renal Denervation on Sympathetic Nervous System Activity 219
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 218
New-onset aortic dilatation in the population: a quarter-century follow-up 218
Elevated heart rate as sympathetic biomarker in human obesity 212
Sympathetic activation in cardiovascular disease: Evidence, clinical impact and therapeutic implications 202
Heart rate as a predictor of cardiovascular risk 201
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS) 199
Age- and sex-specific reference values for media/lumen ratio in small arteries and relationship with risk factors 199
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease 199
Blood pressure measurement, white-coat and masked hypertension 195
Clinical relevance of the sympathetic–vascular interactions in health and disease 193
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 192
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 192
Sympatho-Vagal Imbalance in Hypertension 191
The role of brain in neurogenic prehypertension 190
Obesity and hypertension 190
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 189
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome 189
Sleep Apnea and Hypertension 186
Lercanidipine in the management of hypertension: An update 183
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension 175
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 175
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 174
Assessment of heart rate as 'sympathetic biomarker': Strengths and pitfalls 173
Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study 173
Device-Based Treatment in Hypertension and Heart Failure 172
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction 172
Visit-to-visit blood pressure variability is related to sympathetic neural drive and baroreflex sensitivity in hypertensive patients 171
Cardiovascular physiology: regulation of blood pressure 169
Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment 166
Neural Mechanisms 166
EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON REGIONAL SYMPATHETIC ACTIVITY IN CHRONIC HEART FAILURE 166
Treatment of resistant hypertension 165
Cigarette smoking and the adrenergic nervous system 165
Iatrogenic Aspects of sports cardiology and lifestyle modifications, Chapter 25: Trained Athletes 157
Neurohormonal interactions 157
Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea 154
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 153
The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans 151
Baroreceptor Stimulation 151
Sympathetic Activity in Hypertension and Heart Failure 147
Arterial alterations in hypertension 145
Sympathomodulation in congestive heart failure: From drugs to devices 142
Trained Athletes 139
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure 136
Corrigendum to “Obesity and hypertension” [Pharmacological Research 122 (2017) 1–7](S1043661817304620)(10.1016/j.phrs.2017.05.013) 133
Microvascular Alterations in Obesity 133
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload 129
The sympathetic nervous system in hypertension 128
ASSOCIATION BETWEEN HEART RATE TRESHOLDS FOR CARDIOVASCULAR RISK DEFINED BY NEW ESC/ESH GUIDELINES AND NEUROADRENERGIC MARKERS 109
Totale 18.049
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.659
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022639 0 0 0 0 75 64 64 56 41 89 77 173
2022/20231.521 169 421 170 135 96 250 28 66 100 17 48 21
2023/20241.082 30 34 46 107 155 278 173 25 100 17 16 101
2024/20252.531 150 318 112 92 196 97 169 107 242 372 269 407
2025/20266.245 519 310 489 665 653 319 950 299 455 496 551 539
2026/20272.401 187 599 659 945 11 0 0 0 0 0 0 0
Totale 18.049